Literature DB >> 12107347

Alzheimer's Disease: Genes, Pathogenesis and Risk Prediction.

K. Sleegers1, C.M. Van Duijn.   

Abstract

With the aging of western society the contribution to morbidity of diseases of the elderly, such as dementia, will increase exponentially. Thorough preventative and curative strategies are needed to constrain the increasing prevalence of these disabling diseases. Better understanding of the pathogenesis of disease will enable development of therapy, prevention and the identification of high-risk groups in the population. Here, we review the genetic epidemiology of Alzheimer's disease, the most common cause of dementia in the western world. The search for genetic risk factors, though far from completed, has been of major importance for understanding the pathogenesis of Alzheimer's disease. Although effective therapy is still awaited, these findings have led to new avenues for the development of drugs. Copyright 2002 S. Karger AG, Basel

Entities:  

Year:  2001        PMID: 12107347     DOI: 10.1159/000064193

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  9 in total

1.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis.

Authors:  Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

Review 3.  The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Authors:  Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois
Journal:  Nat Rev Neurosci       Date:  2021-11-23       Impact factor: 34.870

4.  A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.

Authors:  Fan Liu; Alejandro Arias-Vásquez; Kristel Sleegers; Yurii S Aulchenko; Manfred Kayser; Pascual Sanchez-Juan; Bing-Jian Feng; Aida M Bertoli-Avella; John van Swieten; Tatiana I Axenovich; Peter Heutink; Christine van Broeckhoven; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2007-05-29       Impact factor: 11.025

5.  Genetic studies in Alzheimer's disease.

Authors:  Ya-Ping Tang; Elliot S Gershon
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

6.  Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.

Authors:  Juan Yang; Hanzhi Zhao; Yu Ma; Guilai Shi; Jian Song; Yu Tang; Song Li; Ting Li; Nan Liu; Fan Tang; Junjie Gu; Lingling Zhang; Zhuohua Zhang; Xiaohui Zhang; Ying Jin; Weidong Le
Journal:  Oncotarget       Date:  2017-01-31

7.  Association between the Val66Met polymorphism (rs6265/G196A) of the BDNF gene and cognitive performance with SSRI use in Arab Alzheimer's disease patients.

Authors:  N Abanmy; J Alsabhan; P Gard; G Scutt
Journal:  Saudi Pharm J       Date:  2021-10-25       Impact factor: 4.330

Review 8.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

Review 9.  Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.

Authors:  Juan Yang; Song Li; Xi-Biao He; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2016-05-17       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.